Serial #79306375
LIVE

Serial Number

79306375

Owner

Otsuka Pharmaceutical Co., Ltd.

Filing Date

Dec 10, 2020

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79306375 Trademark

Serial Number: 79306375 • Registration: 6635130

Serial #79306375 is a trademark filed by Otsuka Pharmaceutical Co., Ltd. on December 10, 2020. The trademark is classified under Class 5 (Pharmaceuticals), Class 40 (Treatment & Processing), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Otsuka Pharmaceutical Co., Ltd. (566 trademarks)

Chiyoda-ku, Tokyo , JP

Entity Type: 03

TAKARA BIO INC. (51 trademarks)

SETA 3-4-1
OTSU CITY SHIGA , JP

Entity Type: 03

Trademark Details

Filing Date

December 10, 2020

Registration Date

February 8, 2022

Published for Opposition

November 23, 2021

Goods & Services

Custom processing of human cells for medical purposes for others; custom processing of therapeutic cells for medical purposes for others; custom cultivation of human cells as medical materials for others; custom cultivation of human cells for others for medical purposes; custom manufacture of pharmaceuticals; custom manufacture of biopharmaceuticals

Pharmaceutical preparations for the prevention and treatment of cancer; biological preparations for medical purposes for the prevention and treatment of cancer; regenerative preparations for medical purposes, namely, regenerative cell therapy preparations being biological preparations for the prevention and treatment of cancer; cell preparations, namely, human cells for medical purposes for the treatment of diseases and disorders; stem cells for medical purposes; cells for medical use

Medical services; provision of medical information; medical services relating to the removal, treatment and processing of human blood, human cells and stem cells; stem cell therapy services; medical treatment services; medical treatment services with cell preparations; medical treatment services with processed and cultivated cells; human tissue and cell bank services; analysis of human tissues and cells for medical treatment; collection, testing and preservation of human blood, human cells and stem cells for medical purposes

Filing History

CHANGE OF OWNER RECEIVED FROM IB
Apr 27, 2024 CHLD
NEW REPRESENTATIVE AT IB RECEIVED
Mar 13, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 9, 2022 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 16, 2022 FICS
FINAL DISPOSITION PROCESSED
Jul 15, 2022 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 8, 2022 FICR
REGISTERED-PRINCIPAL REGISTER
Feb 8, 2022 R.PR
NOTIFICATION PROCESSED BY IB
Dec 6, 2021 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 23, 2021 NPUB
PUBLISHED FOR OPPOSITION
Nov 23, 2021 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Nov 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Nov 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 3, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 20, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Oct 13, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Oct 12, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Oct 12, 2021 TROA
REFUSAL PROCESSED BY IB
Jul 11, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 24, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jun 24, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jun 17, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jun 16, 2021 CNRT
ASSIGNED TO EXAMINER
Jun 2, 2021 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 23, 2021 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 18, 2021 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 11, 2021 REPR